Insomnia News and Research

Latest Insomnia News and Research

Obstructive sleep apnea increases likelihood of parasomnia symptoms

Patients suffering from obstructive sleep apnea (OSA) have an increased prevalence of parasomnia symptoms compared with the prevalence rates of individual parasomnias, according to a research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.

9 Jun 2009

Insomniacs need increased brain activation to maintain normal daily function

According to a research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, patients suffering from chronic primary insomnia (PIs) have higher levels of brain activation compared to normal sleepers during a working memory test.

9 Jun 2009

Short sleep duration and the risk of obesity among black and white Americans

According to a research abstract presented at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, race significantly influences the risk of obesity conferred by short sleep duration, with blacks having a greater risk than whites.

9 Jun 2009

Link between sleep disorders, diet, exercise and technology use in adolescents

According to a research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, adolescent obesity is associated with having less sleep. Reduction in sleep could be related to a higher caffeine intake, more hours of technology use and increased symptoms of sleep disorders (such as snoring).

9 Jun 2009

Obstructive sleep apnea common in non-obese, middle-aged patients

There is a high probability of obstructive sleep apnea (OSA) in non-obese, middle-aged patients, according to a research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.

9 Jun 2009

Effectiveness of a cognitive-behavioral treatment program for chronic insomnia

A majority of people experiencing chronic insomnia can experience a normalization of sleep parameters through the use of cognitive behavioral therapy for insomnia (CBT-I), according to a research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.

9 Jun 2009

Insomnia and sleep duration linked to diabetes

Individuals with insomnia and objective short sleep duration are at increased risk for developing diabetes, according to a research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.

9 Jun 2009

Effects of meditation on sleep in chronic insomnia

Meditation may be an effective behavioral intervention in the treatment of insomnia, according to a research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies

9 Jun 2009

Research links primary insomnia to specific neurochemical abnormality

A research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, is the first demonstration of a specific neurochemical abnormality in adults with primary insomnia (PI), providing greater insight to the limited understanding of the condition's pathology.

9 Jun 2009

Sleep deprivation a factor in weight gain

The new research by scientists at the University of South Australia has revealed that though their appetites had decreased the study participants gained weight when their sleep was restricted.

8 Jun 2009

HCV protease inhibitor telaprevir improves response, halves treatment time for hepatitis C patients

For patients with the most common form of hepatitis C, the addition of a hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone.

5 Jun 2009

Citalopram no more effective than a placebo for children with autism spectrum disorders

Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to researchers funded by the National Institute of Mental Health (NIMH) and other NIH institutes. The study was published in the June 2009 issue of Archives of General Psychiatry.

1 Jun 2009

Anti-viral drug telaprevir improves response, halves duration of hepatitis C treatment

The addition of the anti-viral drug telaprevir to a standard treatment for hepatitis C can shorten the duration of therapy and increase the number of patients who can be cured of their disease, according to the results of study coordinated by investigators from the Duke Clinical Research Institute (DCRI).

29 Apr 2009

Sleeping leads to increased ratings of pain in cancer patients

A study in the April 15 issue of the Journal of Clinical Sleep Medicine suggests that sleep problems lead to increased pain and fatigue in cancer patients.

15 Apr 2009

Health problems associated with Chinese slimming capsules

Taking herbal food supplements is certainly not free of risk. Since 2005, the poison emergency centers in the German cities of Freiburg and Gottingen have registered a total of 17 patients with health problems after taking Chinese slimming capsules.

8 Apr 2009

Insomnia and short sleep combination a risk factor for hypertension

A study in the April 1 issue of the journal SLEEP is the first to demonstrate that chronic insomnia with objectively measured short sleep time is an independent and clinically significant risk factor for hypertension.

1 Apr 2009

Addressing sleep problems could reduce the risk of suicidal behaviours

In a study presented at the World Psychiatric Association international congress "Treatments in Psychiatry," scientists found that the more types of sleep disturbances people had, the more likely they were to have thoughts of killing themselves, engage in planning a suicidal act or make a suicide attempt.

1 Apr 2009

District Court decision received in Concerta patent sase

The U.S. District Court for the District of Delaware has rendered a decision in the patent litigation between Alza Corporation, McNeil-PPC, Inc. and Andrx Pharmaceuticals LLC. McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., which markets Concerta (methylphenidate HCI) Extended-Release Tablets CII, said the court held that the patent in suit is not valid or infringed by the filing of Andrx's Abbreviated New Drug Application.

1 Apr 2009

Mylan confirms four first-to-file challenges

Mylan Inc. has announced that it and/or a subsidiary have been sued in connection with four separate "first-to-file" Abbreviated New Drug Applications (ANDA) filed with the U.S. Food and Drug Administration (FDA).

29 Mar 2009